Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for IONS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1991. Start Trial.
Date Value
December 31, 2025 2.677B
December 31, 2024 2.303B
December 31, 2023 2.338B
December 31, 2022 1.997B
December 31, 2021 2.131B
December 31, 2020 1.899B
December 31, 2019 2.509B
December 31, 2018 2.085B
December 31, 2017 1.023B
December 31, 2016 667.64M
December 31, 2015 803.98M
December 31, 2014 810.71M
December 31, 2013 708.86M
December 31, 2012 408.07M
December 31, 2011 344.95M
December 31, 2010 472.35M
December 31, 2009 574.31M
December 31, 2008 491.00M
Date Value
December 31, 2007 193.72M
December 31, 2006 193.33M
December 31, 2005 94.39M
December 31, 2004 103.88M
December 31, 2003 215.50M
December 31, 2002 289.35M
December 31, 2001 312.02M
December 31, 2000 127.26M
December 31, 1999 52.84M
December 31, 1998 58.85M
December 31, 1997 86.79M
December 31, 1996 77.62M
December 31, 1995 77.41M
December 31, 1994 43.44M
December 31, 1993 54.03M
December 31, 1992 36.35M
December 31, 1991 61.00M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 2.908B
Biogen, Inc. 3.816B
BridgeBio Pharma, Inc. 588.03M
Vertex Pharmaceuticals, Inc. 6.611B
Arrowhead Pharmaceuticals, Inc. 919.37M